0 XP   0   0   0

Galapagos NV










Financial Health of Galapagos NV




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Richest
#28 / 1194

Total Sales
#53 / 1194

Making Money
#157 / 1194

Working Efficiently
#180 / 1194

Galapagos NV
Buy, Hold or Sell?

Should you buy, hold or sell Galapagos NV?

I guess you are interested in Galapagos NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Galapagos NV

Let's start. I'm going to help you getting a better view of Galapagos NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Galapagos NV even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Galapagos NV is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Galapagos NV. The closing price on 2022-11-28 was €39.15 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Galapagos NV Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Galapagos NV.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Galapagos NV earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Galapagos NV to the Biotechnology industry mean.
  • A Net Profit Margin of -13.8% means that €-0.14 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Galapagos NV:

  • The MRQ is -13.8%. The company is making a huge loss. -2
  • The TTM is -28.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-13.8%TTM-28.6%+14.8%
TTM-28.6%YOY-35.0%+6.4%
TTM-28.6%5Y-45.2%+16.6%
5Y-45.2%10Y-19.5%-25.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.8%-223.6%+209.8%
TTM-28.6%-281.7%+253.1%
YOY-35.0%-344.8%+309.8%
5Y-45.2%-450.1%+404.9%
10Y-19.5%-541.0%+521.5%
1.1.2. Return on Assets

Shows how efficient Galapagos NV is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Galapagos NV to the Biotechnology industry mean.
  • -0.4% Return on Assets means that Galapagos NV generated €0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Galapagos NV:

  • The MRQ is -0.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.4%TTM-0.4%+0.0%
TTM-0.4%YOY-0.9%+0.5%
TTM-0.4%5Y-0.9%+0.5%
5Y-0.9%10Y-0.4%-0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.4%-9.9%+9.5%
TTM-0.4%-8.9%+8.5%
YOY-0.9%-9.3%+8.4%
5Y-0.9%-11.7%+10.8%
10Y-0.4%-12.7%+12.3%
1.1.3. Return on Equity

Shows how efficient Galapagos NV is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Galapagos NV to the Biotechnology industry mean.
  • -0.7% Return on Equity means Galapagos NV generated €-0.01 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Galapagos NV:

  • The MRQ is -0.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.7%TTM-0.8%+0.0%
TTM-0.8%YOY-1.8%+1.0%
TTM-0.8%5Y-1.2%+0.5%
5Y-1.2%10Y-0.6%-0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.7%-12.0%+11.3%
TTM-0.8%-11.5%+10.7%
YOY-1.8%-10.8%+9.0%
5Y-1.2%-14.2%+13.0%
10Y-0.6%-15.2%+14.6%

1.2. Operating Efficiency of Galapagos NV.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Galapagos NV is operating .

  • Measures how much profit Galapagos NV makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Galapagos NV to the Biotechnology industry mean.
  • An Operating Margin of -55.5% means the company generated €-0.55  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Galapagos NV:

  • The MRQ is -55.5%. The company is operating very inefficient. -2
  • The TTM is -45.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-55.5%TTM-45.3%-10.2%
TTM-45.3%YOY-49.4%+4.1%
TTM-45.3%5Y-47.6%+2.3%
5Y-47.6%10Y-26.3%-21.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-55.5%-207.3%+151.8%
TTM-45.3%-271.0%+225.7%
YOY-49.4%-325.9%+276.5%
5Y-47.6%-454.0%+406.4%
10Y-26.3%-537.1%+510.8%
1.2.2. Operating Ratio

Measures how efficient Galapagos NV is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.57 means that the operating costs are €1.57 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Galapagos NV:

  • The MRQ is 1.574. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.480. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.574TTM1.480+0.093
TTM1.480YOY1.534-0.054
TTM1.4805Y2.013-0.533
5Y2.01310Y1.639+0.374
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5742.871-1.297
TTM1.4803.504-2.024
YOY1.5343.604-2.070
5Y2.0135.132-3.119
10Y1.6396.371-4.732

1.3. Liquidity of Galapagos NV.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Galapagos NV is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.23 means the company has €8.23 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Galapagos NV:

  • The MRQ is 8.231. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.492. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.231TTM8.492-0.261
TTM8.492YOY8.799-0.306
TTM8.4925Y7.764+0.729
5Y7.76410Y4.722+3.041
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.2315.117+3.114
TTM8.4925.755+2.737
YOY8.7995.854+2.945
5Y7.7646.511+1.253
10Y4.7226.222-1.500
1.3.2. Quick Ratio

Measures if Galapagos NV is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Galapagos NV to the Biotechnology industry mean.
  • A Quick Ratio of 6.39 means the company can pay off €6.39 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Galapagos NV:

  • The MRQ is 6.392. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.226. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.392TTM5.226+1.166
TTM5.226YOY4.861+0.365
TTM5.2265Y5.098+0.128
5Y5.09810Y2.730+2.369
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.3924.284+2.108
TTM5.2264.664+0.562
YOY4.8614.787+0.074
5Y5.0985.218-0.120
10Y2.7305.182-2.452

1.4. Solvency of Galapagos NV.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Galapagos NV assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Galapagos NV to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.47 means that Galapagos NV assets are financed with 47.5% credit (debt) and the remaining percentage (100% - 47.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Galapagos NV:

  • The MRQ is 0.475. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.489. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.475TTM0.489-0.014
TTM0.489YOY0.522-0.033
TTM0.4895Y0.392+0.097
5Y0.39210Y0.348+0.043
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4750.278+0.197
TTM0.4890.277+0.212
YOY0.5220.306+0.216
5Y0.3920.367+0.025
10Y0.3480.403-0.055
1.4.2. Debt to Equity Ratio

Measures if Galapagos NV is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Galapagos NV to the Biotechnology industry mean.
  • A Debt to Equity ratio of 90.4% means that company has €0.90 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Galapagos NV:

  • The MRQ is 0.904. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.958. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.904TTM0.958-0.054
TTM0.958YOY1.092-0.134
TTM0.9585Y0.747+0.211
5Y0.74710Y0.614+0.133
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9040.315+0.589
TTM0.9580.317+0.641
YOY1.0920.319+0.773
5Y0.7470.403+0.344
10Y0.6140.462+0.152

2. Market Valuation of Galapagos NV

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Galapagos NV generates.

  • Above 15 is considered overpriced but always compare Galapagos NV to the Biotechnology industry mean.
  • A PE ratio of -183.51 means the investor is paying €-183.51 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Galapagos NV:

  • The EOD is -135.456. Company is losing money. -2
  • The MRQ is -183.515. Company is losing money. -2
  • The TTM is -77.454. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-135.456MRQ-183.515+48.058
MRQ-183.515TTM-77.454-106.061
TTM-77.454YOY218.440-295.894
TTM-77.4545Y-3.796-73.658
5Y-3.79610Y-4.998+1.202
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-135.456-8.986-126.470
MRQ-183.515-9.792-173.723
TTM-77.454-16.243-61.211
YOY218.440-20.876+239.316
5Y-3.796-16.665+12.869
10Y-4.998-14.732+9.734
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Galapagos NV.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Galapagos NV:

  • The MRQ is 610.688. Seems overpriced? -1
  • The TTM is 2,811.113. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ610.688TTM2,811.113-2,200.425
TTM2,811.113YOY-43.498+2,854.611
TTM2,811.1135Y3,040.249-229.137
5Y3,040.24910Y2,347.696+692.553
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ610.688-0.032+610.720
TTM2,811.1130.004+2,811.109
YOY-43.4980.016-43.514
5Y3,040.2490.006+3,040.243
10Y2,347.6960.003+2,347.693

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Galapagos NV is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.32 means the investor is paying €1.32 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Galapagos NV:

  • The EOD is 0.974. Very good. +2
  • The MRQ is 1.319. Good. +1
  • The TTM is 1.270. Good. +1
Trends
Current periodCompared to+/- 
EOD0.974MRQ1.319-0.345
MRQ1.319TTM1.270+0.049
TTM1.270YOY1.996-0.725
TTM1.2705Y3.693-2.423
5Y3.69310Y4.886-1.193
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.9741.835-0.861
MRQ1.3192.006-0.687
TTM1.2702.774-1.504
YOY1.9963.453-1.457
5Y3.6932.713+0.980
10Y4.8862.402+2.484
2. Total Gains per Share

2.4. Latest News of Galapagos NV

Does Galapagos NV still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Galapagos NV to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-11-11
13:15
Galapagos announces CHMP adoption of PRAC’s recommendation for Jyseleca® following extensive safety review of all JAK inhibitorsRead
2022-11-08
22:01
Galapagos to present encouraging initial data from FILOSOPHY real-world arthritis study at ACR Convergence 2022Read
2022-11-04
21:01
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022Read
2022-11-03
21:01
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 resultsRead
2022-11-03
21:01
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 resultsRead
2022-11-02
12:15
Strong week for Galapagos (AMS:GLPG) shareholders doesn't alleviate pain of three-year lossRead

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Galapagos NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.005-0.063+1441%-0.417+8983%1.198-100%0.987-100%
Book Value Growth---0.038-0.040+5%-0.049+28%-0.007-82%0.022-273%
Book Value Per Share--40.20540.078+0%40.811-1%31.048+29%18.937+112%
Book Value Per Share Growth--0.000-0.002+1480%-0.010+8866%0.030-100%0.058-100%
Current Ratio--8.2318.492-3%8.799-6%7.764+6%4.722+74%
Debt To Asset Ratio--0.4750.489-3%0.522-9%0.392+21%0.348+36%
Debt To Equity Ratio--0.9040.958-6%1.092-17%0.747+21%0.614+47%
Dividend Per Share----0%-0%-0%-0%
Eps---0.289-0.306+6%-0.484+68%-0.243-16%-0.114-61%
Eps Growth---0.3010.605-150%2.252-113%0.553-154%0.296-202%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.667+50%
Net Profit Margin---0.138-0.286+107%-0.350+153%-0.452+227%-0.195+41%
Operating Margin---0.555-0.453-18%-0.494-11%-0.476-14%-0.263-53%
Operating Ratio--1.5741.480+6%1.534+3%2.013-22%1.639-4%
Pb Ratio0.974-35%1.3191.270+4%1.996-34%3.693-64%4.886-73%
Pe Ratio-135.456+26%-183.515-77.454-58%218.440-184%-3.796-98%-4.998-97%
Peg Ratio--610.6882811.113-78%-43.498+107%3040.249-80%2347.696-74%
Price Per Share39.150-35%53.04050.930+4%81.570-35%96.655-45%66.410-20%
Price To Total Gains Ratio8341.294-35%11300.6963127.381+261%-54.702+100%541.522+1987%343.377+3191%
Profit Growth---27.37864.684-142%179.907-115%48.170-157%23.604-216%
Quick Ratio--6.3925.226+22%4.861+32%5.098+25%2.730+134%
Return On Assets---0.004-0.004+2%-0.009+129%-0.009+143%-0.004+13%
Return On Equity---0.007-0.008+7%-0.018+152%-0.012+73%-0.006-18%
Revenue Growth---0.029-0.240+737%-0.009-68%-0.269+837%-0.235+721%
Total Gains Per Share--0.005-0.063+1441%-0.417+8983%1.198-100%0.987-100%
Total Gains Per Share Growth---9.443-3.474-63%0.270-3597%-2.062-78%-10.066+7%
Usd Book Value--2748009503.6002739350915.600+0%2789480402.600-1%2122151345.690+29%1294319680.718+112%
Usd Book Value Change Per Share--0.005-0.065+1441%-0.433+8983%1.244-100%1.025-100%
Usd Book Value Per Share--41.74141.609+0%42.370-1%32.234+29%19.660+112%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.300-0.318+6%-0.503+68%-0.252-16%-0.118-61%
Usd Price Per Share40.646-35%55.06652.876+4%84.686-35%100.347-45%68.947-20%
Usd Profit---19754869.600-20919989.550+6%-50550217.550+156%-20082681.250+2%-9555672.662-52%
Usd Revenue--142865663.800131108567.900+9%137546965.200+4%132287807.370+8%83125319.815+72%
Usd Total Gains Per Share--0.005-0.065+1441%-0.433+8983%1.244-100%1.025-100%
 EOD+2 -3MRQTTM+24 -8YOY+20 -125Y+17 -1510Y+17 -16

3.2. Fundamental Score

Let's check the fundamental score of Galapagos NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-135.456
Price to Book Ratio (EOD)Between0-10.974
Net Profit Margin (MRQ)Greater than0-0.138
Operating Margin (MRQ)Greater than0-0.555
Quick Ratio (MRQ)Greater than16.392
Current Ratio (MRQ)Greater than18.231
Debt to Asset Ratio (MRQ)Less than10.475
Debt to Equity Ratio (MRQ)Less than10.904
Return on Equity (MRQ)Greater than0.15-0.007
Return on Assets (MRQ)Greater than0.05-0.004
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Galapagos NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.461
Ma 20Greater thanMa 5041.034
Ma 50Greater thanMa 10043.302
Ma 100Greater thanMa 20047.409
OpenGreater thanClose39.100
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets5,040,085
Total Liabilities2,393,187
Total Stockholder Equity2,646,898
 As reported
Total Liabilities 2,393,187
Total Stockholder Equity+ 2,646,898
Total Assets = 5,040,085

Assets

Total Assets5,040,085
Total Current Assets4,533,192
Long-term Assets4,533,192
Total Current Assets
Cash And Cash Equivalents 972,796
Short-term Investments 3,456,184
Net Receivables 64,057
Inventory 27,008
Other Current Assets 13,147
Total Current Assets  (as reported)4,533,192
Total Current Assets  (calculated)4,533,192
+/-0
Long-term Assets
Property Plant Equipment 148,866
Goodwill 174,288
Intangible Assets 32,346
Other Assets 151,393
Long-term Assets  (as reported)506,893
Long-term Assets  (calculated)506,893
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities550,725
Long-term Liabilities1,842,462
Total Stockholder Equity2,646,898
Total Current Liabilities
Accounts payable 160,746
Other Current Liabilities 382,800
Total Current Liabilities  (as reported)550,725
Total Current Liabilities  (calculated)543,546
+/- 7,179
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt24,054
Other Liabilities 1,825,587
Long-term Liabilities  (as reported)1,842,462
Long-term Liabilities  (calculated)1,849,641
+/- 7,179
Total Stockholder Equity
Common Stock293,026
Other Stockholders Equity -11,806
Total Stockholder Equity (as reported)2,646,898
Total Stockholder Equity (calculated)281,220
+/- 2,365,678
Other
Capital Stock293,026
Common Stock Shares Outstanding 65,729
Net Invested Capital 2,646,898
Net Tangible Assets 2,440,264
Net Working Capital 3,982,467



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-31
> Total Assets 
15,613
32,890
32,890
0
81,563
74,389
74,389
156,261
167,646
147,762
147,762
148,724
148,724
119,905
119,905
118,824
118,824
106,216
106,216
143,709
143,709
139,736
139,736
193,961
193,961
152,989
152,989
161,055
161,055
243,337
243,337
235,329
235,329
276,228
276,228
287,374
287,374
304,980
304,980
270,467
0
488,263
461,049
442,514
1,079,287
1,066,524
1,043,094
1,083,338
1,072,814
1,368,355
1,331,373
1,286,274
1,229,864
1,204,348
1,485,551
1,439,496
1,400,200
1,357,848
5,851,752
6,068,609
5,992,406
5,851,564
5,721,086
5,717,731
5,615,059
5,430,617
5,331,987
5,193,160
5,100,315
5,040,085
5,040,0855,100,3155,193,1605,331,9875,430,6175,615,0595,717,7315,721,0865,851,5645,992,4066,068,6095,851,7521,357,8481,400,2001,439,4961,485,5511,204,3481,229,8641,286,2741,331,3731,368,3551,072,8141,083,3381,043,0941,066,5241,079,287442,514461,049488,2630270,467304,980304,980287,374287,374276,228276,228235,329235,329243,337243,337161,055161,055152,989152,989193,961193,961139,736139,736143,709143,709106,216106,216118,824118,824119,905119,905148,724148,724147,762147,762167,646156,26174,38974,38981,563032,89032,89015,613
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
174,622
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,007,232
992,122
1,284,957
1,243,839
1,197,647
1,135,735
1,107,881
1,390,400
1,328,851
1,259,244
1,208,604
5,651,013
5,865,927
5,780,264
5,622,005
5,463,769
5,369,347
5,310,922
5,129,494
5,015,997
4,861,854
4,750,700
4,533,192
4,533,1924,750,7004,861,8545,015,9975,129,4945,310,9225,369,3475,463,7695,622,0055,780,2645,865,9275,651,0131,208,6041,259,2441,328,8511,390,4001,107,8811,135,7351,197,6471,243,8391,284,957992,1221,007,23200000000000000174,62200000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124,417
0
0
0
0
0
0
0
0
0
0
0
0
0
0
973,241
953,385
1,262,061
1,218,856
1,151,211
1,108,186
1,066,766
1,343,668
1,290,796
1,222,901
198,994
4,270,724
1,861,616
2,743,573
2,384,220
2,087,797
2,135,187
2,553,950
2,642,639
2,834,378
2,233,368
1,254,279
972,796
972,7961,254,2792,233,3682,834,3782,642,6392,553,9502,135,1872,087,7972,384,2202,743,5731,861,6164,270,724198,9941,222,9011,290,7961,343,6681,066,7661,108,1861,151,2111,218,8561,262,061953,385973,24100000000000000124,41700000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,919,216
2,978,805
3,182,276
3,220,805
3,026,278
2,560,743
2,363,969
2,039,787
2,469,809
3,389,098
3,456,184
3,456,1843,389,0982,469,8092,039,7872,363,9692,560,7433,026,2783,220,8053,182,2762,978,8053,919,21600000000000000000000000000000000000000000000000000000000000
       Net Receivables 
2,169
2,120
2,120
0
9,786
5,729
5,729
24,846
24,847
24,702
24,702
26,500
23,581
19,761
19,761
26,427
26,427
20,131
20,131
32,489
32,489
26,173
26,173
63,546
63,546
14,304
14,304
28,857
28,857
16,083
16,083
33,242
33,242
26,540
26,540
31,979
31,979
20,061
20,061
13,794
0
11,801
19,163
16,057
15,075
17,625
18,127
23,479
26,164
15,642
17,740
41,789
20,086
33,762
37,006
33,533
26,992
42,067
32,642
80,110
49,180
45,190
139,299
173,399
180,347
113,600
126,802
128,601
78,521
64,057
64,05778,521128,601126,802113,600180,347173,399139,29945,19049,18080,11032,64242,06726,99233,53337,00633,76220,08641,78917,74015,64226,16423,47918,12717,62515,07516,05719,16311,801013,79420,06120,06131,97931,97926,54026,54033,24233,24216,08316,08328,85728,85714,30414,30463,54663,54626,17326,17332,48932,48920,13120,13126,42726,42719,76119,76123,58126,50024,70224,70224,84724,8465,7295,7299,78602,1202,1202,169
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
2,919
0
0
2,532
2,532
1,604
1,604
2,990
2,990
3,139
3,139
3,843
3,843
2,193
2,193
3,647
3,647
4,522
4,522
4,634
4,634
4,520
4,520
2,944
2,944
3,005
3,005
1,394
0
5,751
4,653
10,918
5,642
6,981
6,848
3,642
8,215
6,936
6,939
4,368
7,170
7,086
9,446
4,104
9,351
6,970
8,838
4,438
8,706
10,319
15,868
33,909
15,882
9,286
15,030
9,305
10,404
13,147
13,14710,4049,30515,0309,28615,88233,90915,86810,3198,7064,4388,8386,9709,3514,1049,4467,0867,1704,3686,9396,9368,2153,6426,8486,9815,64210,9184,6535,75101,3943,0053,0052,9442,9444,5204,5204,6344,6344,5224,5223,6473,6472,1932,1933,8433,8433,1393,1392,9902,9901,6041,6042,5322,532002,919000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
140,956
149,244
200,739
202,682
212,142
229,559
257,318
348,384
304,136
301,123
315,990
331,306
349,615
506,893
506,893349,615331,306315,990301,123304,136348,384257,318229,559212,142202,682200,739149,244140,95600000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
2,625
2,669
2,669
0
9,399
9,939
9,939
25,540
25,965
26,013
26,013
22,914
22,914
21,135
21,135
20,293
20,293
20,542
20,542
19,285
19,285
20,473
20,473
23,886
23,886
20,310
20,310
19,524
19,524
19,253
19,253
18,099
18,099
17,273
17,273
19,525
19,525
10,761
10,761
10,091
0
11,178
12,577
13,782
14,110
15,091
15,032
14,961
15,064
15,506
15,279
16,692
16,971
17,854
18,113
23,137
49,542
51,180
61,883
66,052
66,979
73,786
94,661
103,378
111,294
111,900
123,637
137,512
145,896
148,866
148,866145,896137,512123,637111,900111,294103,37894,66173,78666,97966,05261,88351,18049,54223,13718,11317,85416,97116,69215,27915,50615,06414,96115,03215,09114,11013,78212,57711,178010,09110,76110,76119,52519,52517,27317,27318,09918,09919,25319,25319,52419,52420,31020,31023,88623,88620,47320,47319,28519,28520,54220,54220,29320,29321,13521,13522,91422,91426,01326,01325,96525,5409,9399,9399,39902,6692,6692,625
       Goodwill 
0
0
0
0
29,481
29,112
29,112
32,996
35,560
35,948
35,948
33,952
33,952
33,952
33,952
33,751
33,751
33,751
33,751
33,751
33,751
42,710
42,710
42,380
42,380
38,880
38,880
38,880
38,880
38,314
38,314
37,667
37,667
39,240
39,240
39,239
39,239
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
174,288
174,2880000000000000000000000000000000039,23939,23939,24039,24037,66737,66738,31438,31438,88038,88038,88038,88042,38042,38042,71042,71033,75133,75133,75133,75133,75133,75133,95233,95233,95233,95235,94835,94835,56032,99629,11229,11229,4810000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,524
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,754
0
0
0
6,000
0
0
0
11,275
0
0
0
8,951
0
0
0
0
0
0
0000008,95100011,2750006,0000001,75400000000000000000046,52400000000000000000000000000000000
       Intangible Assets 
447
422
422
0
34,350
33,690
33,690
42,445
53,404
53,164
53,164
40,042
40,042
40,019
40,019
37,910
37,910
37,960
37,960
37,231
37,231
58,248
58,248
55,914
55,914
50,068
50,068
49,494
49,494
48,135
48,135
47,091
47,091
47,768
47,768
47,071
47,071
1,862
1,862
2,015
0
1,575
1,517
1,550
1,382
1,226
1,150
1,023
963
859
747
2,495
2,555
1,403
2,058
3,632
6,497
7,191
23,492
24,927
33,856
39,254
41,114
67,566
65,738
63,072
59,623
60,103
0
32,346
32,346060,10359,62363,07265,73867,56641,11439,25433,85624,92723,4927,1916,4973,6322,0581,4032,5552,4957478599631,0231,1501,2261,3821,5501,5171,57502,0151,8621,86247,07147,07147,76847,76847,09147,09148,13548,13549,49449,49450,06850,06855,91455,91458,24858,24837,23137,23137,96037,96037,91037,91040,01940,01940,04240,04253,16453,16453,40442,44533,69033,69034,3500422422447
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,377
5,713
5,993
28,164
13,945
9,522
8,647
37,504
4,465
4,422
4,455
2,472
7,881
8,388
8,3887,8812,4724,4554,4224,46537,5048,6479,52213,94528,1645,9935,7136,37700000000000000000000000000000000000000000000000000000000
> Total Liabilities 
5,246
5,044
5,044
0
20,427
18,591
18,591
46,719
58,104
43,574
43,574
50,098
50,098
31,674
31,674
34,500
34,500
26,975
26,975
34,832
34,832
36,555
36,555
45,455
45,455
34,697
34,697
42,679
42,679
130,997
130,997
116,882
116,882
108,216
108,216
120,237
120,237
79,965
79,965
64,332
0
44,808
42,258
77,515
350,742
336,724
334,272
324,637
324,664
299,329
294,441
274,291
330,519
318,689
297,329
225,247
224,445
214,481
3,316,471
3,192,951
3,152,365
3,078,301
3,009,004
3,047,376
2,913,597
2,767,144
2,714,604
2,549,798
2,453,726
2,393,187
2,393,1872,453,7262,549,7982,714,6042,767,1442,913,5973,047,3763,009,0043,078,3013,152,3653,192,9513,316,471214,481224,445225,247297,329318,689330,519274,291294,441299,329324,664324,637334,272336,724350,74277,51542,25844,808064,33279,96579,965120,237120,237108,216108,216116,882116,882130,997130,99742,67942,67934,69734,69745,45545,45536,55536,55534,83234,83226,97526,97534,50034,50031,67431,67450,09850,09843,57443,57458,10446,71918,59118,59120,42705,0445,0445,246
   > Total Current Liabilities 
3,608
3,688
3,688
0
14,065
12,305
12,305
29,655
29,278
22,704
22,704
43,361
43,361
25,532
25,532
29,751
29,751
22,787
22,787
31,344
31,344
28,053
28,053
38,223
38,223
27,818
27,818
35,360
35,360
124,367
124,367
109,014
109,014
99,294
99,294
112,559
112,559
75,977
75,977
60,357
0
40,299
37,251
72,412
104,736
111,549
129,826
103,791
127,984
130,678
154,531
171,699
223,631
246,586
269,102
219,905
199,450
188,712
631,300
571,793
622,626
618,538
601,744
635,274
605,362
576,985
575,494
566,474
562,896
550,725
550,725562,896566,474575,494576,985605,362635,274601,744618,538622,626571,793631,300188,712199,450219,905269,102246,586223,631171,699154,531130,678127,984103,791129,826111,549104,73672,41237,25140,299060,35775,97775,977112,559112,55999,29499,294109,014109,014124,367124,36735,36035,36027,81827,81838,22338,22328,05328,05331,34431,34422,78722,78729,75129,75125,53225,53243,36143,36122,70422,70429,27829,65512,30512,30514,06503,6883,6883,608
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
316
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63
50
37
23
9
0
0
0
0
4,580
5,141
0
0
0
0
0
0
0
0
0
0
0
0
0000000000005,1414,58000009233750630000000000000031600000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
316
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63
50
37
23
9
0
0
0
0
4,580
5,141
0
0
0
0
0
0
0
0
0
0
0
0
0000000000005,1414,58000009233750630000000000000031600000000000000000000000000000000
       Accounts payable 
2,766
3,042
3,042
0
9,568
9,711
9,711
11,805
25,431
18,631
18,631
13,293
13,293
23,588
23,588
13,425
13,425
11,850
11,850
15,130
15,130
12,556
12,556
22,012
22,012
16,107
16,107
18,068
18,068
15,739
15,739
22,093
22,093
20,449
20,449
29,365
29,365
23,047
23,047
29,344
0
32,823
32,775
29,113
24,223
22,673
27,749
31,209
46,964
36,686
48,437
47,122
55,657
69,141
80,721
68,038
69,880
86,216
156,254
142,511
169,477
179,432
157,259
171,316
161,867
151,721
145,260
134,304
134,668
160,746
160,746134,668134,304145,260151,721161,867171,316157,259179,432169,477142,511156,25486,21669,88068,03880,72169,14155,65747,12248,43736,68646,96431,20927,74922,67324,22329,11332,77532,823029,34423,04723,04729,36529,36520,44920,44922,09322,09315,73915,73918,06818,06816,10716,10722,01222,01212,55612,55615,13015,13011,85011,85013,42513,42523,58823,58813,29313,29318,63118,63125,43111,8059,7119,7119,56803,0423,0422,766
       Other Current Liabilities 
736
536
536
0
1,530
594
594
14,678
675
383
383
27,447
27,447
850
850
15,796
15,796
10,682
10,682
15,694
15,694
15,078
15,078
15,833
15,833
11,315
11,315
16,867
16,867
108,222
108,222
86,681
86,681
78,599
78,599
82,968
82,968
52,816
52,816
30,961
0
7,425
4,425
43,247
80,461
88,823
102,024
72,528
80,970
93,955
106,071
124,568
167,974
176,584
187,514
150,977
124,990
-1
-1
422,533
446,939
432,234
437,369
456,487
437,020
418,784
422,972
421,852
421,163
382,800
382,800421,163421,852422,972418,784437,020456,487437,369432,234446,939422,533-1-1124,990150,977187,514176,584167,974124,568106,07193,95580,97072,528102,02488,82380,46143,2474,4257,425030,96152,81652,81682,96882,96878,59978,59986,68186,681108,222108,22216,86716,86711,31511,31515,83315,83315,07815,07815,69415,69410,68210,68215,79615,79685085027,44727,44738338367514,6785945941,5300536536736
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,995
25,769
2,685,171
2,621,158
2,529,739
2,459,763
2,407,260
2,412,102
2,308,235
2,190,159
2,139,110
1,983,324
1,890,830
1,842,462
1,842,4621,890,8301,983,3242,139,1102,190,1592,308,2352,412,1022,407,2602,459,7632,529,7392,621,1582,685,17125,76924,99500000000000000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,457
19,661
19,558
18,856
20,384
0
0
0
0
0
0
0
0
0000000020,38418,85619,55819,66120,457000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
214
63
63
11,875
23,637
18,110
18,110
4,698
4,698
4,252
4,252
3,392
3,392
2,531
2,531
1,960
1,960
2,704
2,704
3,672
3,672
3,813
3,813
4,465
4,465
4,381
4,381
5,079
5,079
6,074
6,074
5,319
5,319
3,848
3,848
3,860
0
4,420
4,931
5,040
245,956
225,138
204,423
220,837
196,680
168,651
139,910
102,592
106,888
72,103
28,227
5,342
4,586
5,312
2,665,510
2,601,600
2,510,883
2,439,379
2,385,310
2,389,066
2,286,059
2,168,730
2,119,982
1,963,669
1,872,541
1,825,587
1,825,5871,872,5411,963,6692,119,9822,168,7302,286,0592,389,0662,385,3102,439,3792,510,8832,601,6002,665,5105,3124,5865,34228,22772,103106,888102,592139,910168,651196,680220,837204,423225,138245,9565,0404,9314,42003,8603,8483,8485,3195,3196,0746,0745,0795,0794,3814,3814,4654,4653,8133,8133,6723,6722,7042,7041,9601,9602,5312,5313,3923,3924,2524,2524,6984,69818,11018,11023,63711,87563632140000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,460
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,872
0
0
0
13,334
0
0
0
11,796
0
0
0011,79600013,33400014,872000000000000000000000000003,46000000000000000000000000000000000
> Total Stockholder Equity
10,367
27,846
27,846
27,846
61,136
55,798
55,798
109,542
109,542
104,188
104,188
98,626
98,626
88,231
88,231
84,324
84,324
79,241
79,241
108,877
108,877
103,181
103,181
148,506
148,506
118,292
118,292
118,376
118,376
112,340
112,340
118,447
118,447
168,012
168,012
167,137
167,137
225,015
225,015
206,135
206,135
443,455
418,791
364,999
728,545
729,800
708,822
758,701
748,150
1,069,026
1,036,932
1,011,983
899,345
885,659
1,188,222
1,214,249
1,175,755
1,143,367
2,535,281
2,875,658
2,840,041
2,773,263
2,712,082
2,670,355
2,701,462
2,663,473
2,617,383
2,643,362
2,646,589
2,646,898
2,646,8982,646,5892,643,3622,617,3832,663,4732,701,4622,670,3552,712,0822,773,2632,840,0412,875,6582,535,2811,143,3671,175,7551,214,2491,188,222885,659899,3451,011,9831,036,9321,069,026748,150758,701708,822729,800728,545364,999418,791443,455206,135206,135225,015225,015167,137167,137168,012168,012118,447118,447112,340112,340118,376118,376118,292118,292148,506148,506103,181103,181108,877108,87779,24179,24184,32484,32488,23188,23198,62698,626104,188104,188109,542109,54255,79855,79861,13627,84627,84627,84610,367
   Retained Earnings -367,381-366,119-367,205-391,311-345,101-306,881-334,701-297,098-235,224-150,597-109,223-4,642-377,253-340,020-297,779-321,495-343,796-328,620-211,441-186,432-154,553-122,854-112,27200000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,283,650
2,268,585
2,703,583
2,708,114
2,723,671
0
0
0
0
0
0
0
0
000000002,723,6712,708,1142,703,5832,268,5851,283,650000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.